Monti E - Search Results

1

Purification of interleukin-2 antibodies from healthy individuals.

Monti E, Pozzi A, Tiberio L, Morelli D, Caruso A, Villa ML, Balsari A. Monti E, et al. Immunol Lett. 1993 Jun;36(3):261-6. doi: 10.1016/0165-2478(93)90098-m. Immunol Lett. 1993. PMID: 8370597

2

Inhibition of the biological activity of human interferon-gamma by antipeptide antibodies.

Caruso A, Viani E, Tiberio L, Pollara P, Monti E, Bonfanti C, Gao J, Landolfo S, Balsari A, Turano A. Caruso A, et al. Among authors: monti e. J Interferon Res. 1992 Feb;12(1):49-54. doi: 10.1089/jir.1992.12.49. J Interferon Res. 1992. PMID: 1573282

3

High-titre antibodies to a foreign epitope elicited by affinity-purified hybrid LamB proteins.

Gargiulo F, Monti E, Caruso A, Manca N, Martinelli F, De Rango C, Flamminio G, Gao J, Preti A, Turano A. Gargiulo F, et al. Among authors: monti e. Vaccine. 1993;11(11):1093-6. doi: 10.1016/0264-410x(93)90067-8. Vaccine. 1993. PMID: 7504378

4

The detection and biological activity of human antibodies to IL-2 in normal donors.

Tiberio L, Caruso A, Pozzi A, Rivoltini L, Morelli D, Monti E, Balsari A. Tiberio L, et al. Among authors: monti e. Scand J Immunol. 1993 Nov;38(5):472-6. doi: 10.1111/j.1365-3083.1993.tb02590.x. Scand J Immunol. 1993. PMID: 8235450

5

A monoclonal antibody to the NH2-terminal segment of human IFN-gamma selectively interferes with the antiproliferative activity of the lymphokine.

Caruso A, Tiberio L, De Rango C, Bonfanti C, Flamminio G, Gribaudo G, Monti E, Viani E, Manca N, Garotta G, et al. Caruso A, et al. Among authors: monti e. J Immunol. 1993 Feb 1;150(3):1029-35. J Immunol. 1993. PMID: 8423329

6

Purification of LamB proteins using continuous elution electrophoresis: a comparison with immunoaffinity chromatography.

Flamminio G, Monti E, Gargiulo F, varinacci C, Magni P, Martinelli F, Caimi L, Caruso A, Preti A, Turano A. Flamminio G, et al. Among authors: monti e. Biochem Mol Biol Int. 1995 Aug;36(6):1255-61. Biochem Mol Biol Int. 1995. PMID: 8535297

7

Overexpression of wild-type and mutant mucolipin proteins in mammalian cells: effects on the late endocytic compartment organization.

Manzoni M, Monti E, Bresciani R, Bozzato A, Barlati S, Bassi MT, Borsani G. Manzoni M, et al. Among authors: monti e. FEBS Lett. 2004 Jun 4;567(2-3):219-24. doi: 10.1016/j.febslet.2004.04.080. FEBS Lett. 2004. PMID: 15178326 Free article.

8

Expression of activated VEGFR2 by R1051Q mutation alters the energy metabolism of Sk-Mel-31 melanoma cells by increasing glutamine dependence.

Grillo E, Corsini M, Ravelli C, Zammataro L, Bacci M, Morandi A, Monti E, Presta M, Mitola S. Grillo E, et al. Among authors: monti e. Cancer Lett. 2021 Jun 1;507:80-88. doi: 10.1016/j.canlet.2021.03.007. Epub 2021 Mar 17. Cancer Lett. 2021. PMID: 33744390

9

A novel variant of VEGFR2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasis.

Grillo E, Corsini M, Ravelli C, di Somma M, Zammataro L, Monti E, Presta M, Mitola S. Grillo E, et al. Among authors: monti e. Cancer Lett. 2021 Jan 1;496:84-92. doi: 10.1016/j.canlet.2020.09.027. Epub 2020 Oct 6. Cancer Lett. 2021. PMID: 33035615

10

Caveolin-1 promotes radioresistance in rhabdomyosarcoma through increased oxidative stress protection and DNA repair.

Codenotti S, Marampon F, Triggiani L, Bonù ML, Magrini SM, Ceccaroli P, Guescini M, Gastaldello S, Tombolini V, Poliani PL, Asperti M, Poli M, Monti E, Fanzani A. Codenotti S, et al. Among authors: monti e. Cancer Lett. 2021 May 1;505:1-12. doi: 10.1016/j.canlet.2021.02.005. Epub 2021 Feb 18. Cancer Lett. 2021. PMID: 33610729

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

382 results

Search Page

Filters